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We have previously shown that miR-143 is down-
regulated in colorectal cancer and that miR-143 over-
expression in HCT116 cells increases sensitivity to
5-fluorouracil, reduces cell viability and increases
apoptosis in vitro. In the present study, we evaluated the
role of miR-143 over-expression on HCT116 xenograft
tumor growth in nude mice. HCT116 cells with stable
miR-143 over-expression (over-143) and control (empty)
cells were injected s.c. into the backs of nude mice, and
tumor growth was evaluated. Tumors arose approxi-
mately 14 days later, and the experiment was ended 40
days after injection. miR-143 was confirmed to be signif-
icantly over-expressed in over-143versusempty xeno-
grafts, by Taqman real-time PCR. Over-143 xenografts
displayed slower tumor growth compared to empty
xenografts, with significantly smaller tumor volumes,
from 23 until 40 days in vivo (p<0.05), with final
volumes of 928 ± 338 and 2312 ± 387 mm
3, respec-
tively. Evaluation of apoptotic proteins showed that
over-143versusempty xenografts, display reduced Bcl-2
expression, and increased caspase-3 activation and
PARP cleavage (p<0.05). In addition, the incidence of
apoptotic cells, assessed by TUNEL, was increased in
over-143versusempty xenografts. Therefore, our results
suggest that the reduced tumor volume may, in part, be
due to increased miR-143-induced apoptosis. Collec-
tively, our results reinforce the relevance of miR-143 in
colorectal cancer, suggesting an important role in the
control of in vivo tumor progression. This further
expands its anti-proliferative, pro-apoptotic and chemo-
sensitizer role that we have previously demonstrated
in vitro.
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